ANTHRASIL

Anthrax immune globulin intravenous (AIGIV) · Emergent BioSolutions

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANTHRASIL, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients